FIELD: medicine. SUBSTANCE: the preparation contains as an active substance 1-desoxy-1-N-[methyl-(2- acridone-9-on- 10-il-acetate)]-ammonium-D-glucitol (I), and as a stabilizer - N-methylglucamine (II), as a solvent - water for injections (III) at the following ratio of components, weight%: I - 8.5-25.0%, II - 0.05- 1.00%, III - up to 100%. EFFECT: increased biological activity of preparation and stability of its medicinal form during production and storage processes. 5 ex, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING A MEDICINAL PREPARATION FOR PARENTERAL APPLICATION | 2020 |
|
RU2739247C1 |
ANTIVIRAL MEDICINAL PREPARATION FOR ORAL USAGE | 2002 |
|
RU2203671C1 |
WOUND-HEALING, ANTI-INFLAMMATORY AND ANTI-INFECTIOUS MEDICINAL PREPARATION | 2000 |
|
RU2173155C1 |
SOLID DOSAGED FORM FOR ORAL USING SHOWING ANTIVIRAL ACTIVITY (VARIANTS) | 1995 |
|
RU2115415C1 |
MEDICINAL AGENT FOR TUMOR DISEASE TREATMENT | 1993 |
|
RU2076710C1 |
MEDICINAL AGENT FOR ATHEROSCLEROSIS AND ITS COMPLICATION TREATMENT | 1993 |
|
RU2071768C1 |
MEDICINAL AGENT FOR MULTIPLE SCLEROSIS TREATMENT | 1993 |
|
RU2071772C1 |
MEDICINAL AGENT FOR TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROMES, AMONG THEM HIV-DEPENDED | 1993 |
|
RU2071773C1 |
METHOD OF PRODUCING WATER-SOLUBLE LYOPHILISATE OF 4-(3-OXO-3-ETHOXYPROPANOYL)AMINO)BENZOIC ACID POSSESSING ANTI-ISCHEMIC AND ANTIOXIDANT ACTIVITY | 2015 |
|
RU2602665C1 |
DISINTOXICATING INFUSION SOLUTION | 2003 |
|
RU2240116C1 |
Authors
Dates
2002-05-10—Published
2001-02-22—Filed